Literature DB >> 14571229

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.

Jeffrey B Schwimmer1, Reena Deutsch, Jeffrey B Rauch, Cynthia Behling, Robert Newbury, Joel E Lavine.   

Abstract

OBJECTIVE: To describe the clinical characteristics of nonalcoholic fatty liver disease (NAFLD) in children, including insulin resistance, and to test for correlation with liver pathology. STUDY
DESIGN: A retrospective review of children with biopsy-proven NAFLD at Children's Hospital San Diego from 1999 to 2002. Liver biopsy specimens were independently reviewed by two pathologists.
RESULTS: Children with NAFLD (n=43) were mostly male (70%), Hispanic American (53%) and obese (88%). The criteria for insulin resistance were met by 95% of subjects. Steatosis was predicted by the combination of quantitative insulin sensitivity check index, age, and ethnicity (P<.0001). Portal inflammation was predicted by the combination of ALT and fasting insulin (P=.0009). Perisinusoidal fibrosis was predicted by the combination of AST, fasting insulin, and BMI Z score (P<.0001). Portal fibrosis was predicted by the combination of right upper quadrant pain and homeostasis model assessment of insulin resistance (P=.0028).
CONCLUSIONS: We identified significant predictors of liver pathology in children with NAFLD. Children being evaluated for NAFLD should be screened for insulin resistance, which is nearly universal and correlates with liver histology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14571229     DOI: 10.1067/S0022-3476(03)00325-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  127 in total

1.  Overview of screening methods for fatty liver disease in children.

Authors:  Caroline Anitha Devadason; Ann O Scheimann
Journal:  World J Hepatol       Date:  2012-01-27

2.  Fatty liver disease in children: eat now pay later.

Authors:  Ruth M L De Bruyne; Emer Fitzpatrick; Anil Dhawan
Journal:  Hepatol Int       Date:  2010-01-29       Impact factor: 6.047

3.  Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology.

Authors:  Yoshihisa Takahashi; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

4.  Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment.

Authors:  B G P Koot; O H van der Baan-Slootweg; S Vinke; A E Bohte; C L J Tamminga-Smeulders; P L M Jansen; J Stoker; M A Benninga
Journal:  Int J Obes (Lond)       Date:  2015-08-28       Impact factor: 5.095

5.  Pediatric obesity. An introduction.

Authors:  Jack A Yanovski
Journal:  Appetite       Date:  2015-03-30       Impact factor: 3.868

6.  Nonalcoholic fatty liver disease.

Authors:  Diana Mager; Eve Roberts
Journal:  CMAJ       Date:  2005-09-27       Impact factor: 8.262

Review 7.  Development of type 2 diabetes in children and adolescents.

Authors:  Ram Weiss; Sara E Taksali; Sonia Caprio
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

8.  Bariatric surgery in adolescents and young adults--safety and effectiveness in a cohort of 345 patients.

Authors:  B S Lennerz; M Wabitsch; H Lippert; S Wolff; C Knoll; R Weiner; T Manger; W Kiess; C Stroh
Journal:  Int J Obes (Lond)       Date:  2013-09-19       Impact factor: 5.095

9.  Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women.

Authors:  Jennifer L Rehm; Peter M Wolfgram; Diego Hernando; Jens C Eickhoff; David B Allen; Scott B Reeder
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

10.  Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease.

Authors:  Miriam B Vos; Shirish Barve; Swati Joshi-Barve; John D Carew; Peter F Whitington; Craig J McClain
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-10       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.